Login / Signup
CCL2 regulated by the CTBP1-AS2/miR-335-5p axis promotes hemangioma progression and angiogenesis.
Ruixuan Li
Ying Liu
Jianfeng Liu
Bo Chen
Zhongjie Ji
Aixia Xu
Tianhua Zhang
Published in:
Immunopharmacology and immunotoxicology (2024)
Our findings suggest that targeting the CTBP1-AS2/miR-335-5p/CCL2 axis may hold promise as a therapeutic strategy for HA.
Keyphrases
</>
liver fibrosis
liver injury
endothelial cells
drug induced
vascular endothelial growth factor
cancer therapy
big data